Crossmark

Eficacia de la inducción extendida intravenosa con risankizumab en enfermedad de Crohn refractaria

Crossref DOI link: https://doi.org/10.1016/j.gastrohep.2025.502635

Published Print: 2026-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Rodríguez Amado, Marcos A. https://orcid.org/0009-0002-9769-8961
Villalba Campano, Aitor

Ruiz Sierras, María

Ortiz Pérez, Begoña

Rubín de Célix, Cristina

Bermejo, Fernando
License Information

Text and Data Mining valid from 2026-03-01

Text and Data Mining valid from 2026-03-01

stm-asf valid from 2026-03-01

stm-asf valid from 2026-03-01

stm-asf valid from 2026-03-01

stm-asf valid from 2026-03-01

stm-asf valid from 2026-03-01
More Information

This article is maintained by: Elsevier

Article Title: Eficacia de la inducción extendida intravenosa con risankizumab en enfermedad de Crohn refractaria

Journal Title: Gastroenterología y Hepatología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastrohep.2025.502635

Content Type: simple-article

Copyright: © 2025 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.